Novo Nordisk to phase out country’s largest insulin brand
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard…
USV Joins Empagliflozin generic contest, launches its brand Xenia
New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…